These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7704567)
1. Parkinson's disease--a single clinical entity? Brooks DJ QJM; 1995 Feb; 88(2):81-91. PubMed ID: 7704567 [No Abstract] [Full Text] [Related]
2. Etiology of Parkinson's disease: contributions from 18F-DOPA positron emission tomography. Piccini P; Brooks DJ Adv Neurol; 1999; 80():227-31. PubMed ID: 10410726 [No Abstract] [Full Text] [Related]
3. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? Sawle GV Mov Disord; 1993 Jul; 8(3):271-7. PubMed ID: 8341290 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism. Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398 [No Abstract] [Full Text] [Related]
5. Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. Nicholl DJ; Vaughan JR; Khan NL; Ho SL; Aldous DE; Lincoln S; Farrer M; Gayton JD; Davis MB; Piccini P; Daniel SE; Lennox GG; Brooks DJ; Williams AC; Wood NW Brain; 2002 Jan; 125(Pt 1):44-57. PubMed ID: 11834592 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease. First of two parts. Lang AE; Lozano AM N Engl J Med; 1998 Oct; 339(15):1044-53. PubMed ID: 9761807 [No Abstract] [Full Text] [Related]
9. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease. Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? Halliday G; McCann H; Shepherd C Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170 [TBL] [Abstract][Full Text] [Related]
11. Neuropathology of Lewy body disorders. Kövari E; Horvath J; Bouras C Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266 [TBL] [Abstract][Full Text] [Related]
14. [Positron-emission tomographic studies of the brain in parkinsonism patients]. Berezhkova LV Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(6):93-7. PubMed ID: 8788992 [No Abstract] [Full Text] [Related]
16. The rate of progression of Parkinson's disease. Sawle GV Ann Neurol; 1992 Feb; 31(2):229. PubMed ID: 1575462 [No Abstract] [Full Text] [Related]
17. Etiology and pathogenesis of Parkinson's disease. Schapira AH; Jenner P Mov Disord; 2011 May; 26(6):1049-55. PubMed ID: 21626550 [TBL] [Abstract][Full Text] [Related]
18. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease. Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732 [No Abstract] [Full Text] [Related]
19. Dementia in Parkinson's disease challenges the "gold standard". Levy G Ann Neurol; 2005 Nov; 58(5):663-5. PubMed ID: 16240335 [No Abstract] [Full Text] [Related]
20. Missing pieces in the Parkinson's disease puzzle. Obeso JA; Rodriguez-Oroz MC; Goetz CG; Marin C; Kordower JH; Rodriguez M; Hirsch EC; Farrer M; Schapira AH; Halliday G Nat Med; 2010 Jun; 16(6):653-61. PubMed ID: 20495568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]